Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

ohm: Thanks to the good offices of board moderator

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154633
(Total Views: 758)
Posted On: 11/15/2021 4:25:51 PM
Posted By: Jake2212
Re: ohm20 #110525
ohm: Thanks to the good offices of board moderator, NuGilead, my 5 post limit has been removed. As to subpoenas re NSF, none would be necessary if, as Buddy just posted, USF is indeed a named defendant. However, as to the amount of exerted control necessary to pierce the corporate veil, and keeping in mind that I'm several decades removed from the law school class that would have addressed the necessary elements to do so, my recollection is that the case law imposes a high burden on attempts to so. I would also imagine that Sidley, in naming NSF a defendant, would have expressly pled piercing the corporate veil or some other legal theory that would create either direct or vicarious liability on NSF. (Simply owning Amarex or agreeing to investigate CYDY's complaints, however, would not, in itself, make USF liable for Amarex's contractual breeches or tortious misconduct.)

Moreover, if Buddy is correct that CYDY's complaint only seeks injunctive relief, then NSF isn't even a necessary party, and monetary damages are likely not involved. But there certainly could be separate damages discussions as part of settling the arbitration case. As in Amarex waiving its claim to additional fees and returning fees previously paid by CYDY. This is speculation, however.

Finally, Evil responded to one of my earlier posts by arguing that NSF might be motivated to drive an ultimate settlement simply to protect its investment in Amarex. I apologize if I didn't express myself clearly enough in the post to which he responded, but I was trying to make that very point. But, as I previously attempted to explain, that motivation would increase substantially if Sidley has a viable cause of action to assert against NSF itself.


(13)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us